Xeris Biopharma Holdings, Inc. Contracts & Agreements
11 Contracts & Agreements
- Business Finance (4 contracts)
- Business Operations (1)
- Human Resources (4)
- Uncategorized (2)
- Second Amendment to API Supply Agreement, dated as of May 2, 2022, by and between (Filed With SEC on August 10, 2022)
- Open Market Sale Agreement (Filed With SEC on May 11, 2022)
- Form of Warrant to purchase common stock by and between the Registrant and Hayfin Services LLP (Filed With SEC on May 11, 2022)
- Amended and Restated Employment Agreement by and among the Registrant, Xeris Pharmaceuticals, Inc. and Beth Hecht dated as of October 5, 2021 (Filed With SEC on May 11, 2022)
- Description of Registrant's Securities (Filed With SEC on March 11, 2022)
- Form of Warrant (Filed With SEC on January 3, 2022)
- Form of Securities Purchase Agreement between the Company and Armistice Capital Master Fund Ltd. dated as of January 2, 2022 (Filed With SEC on January 3, 2022)
- Form of Registration Rights Agreement between the Company and Armistice Capital Master Fund Ltd. dated as of January 2, 2022 (Filed With SEC on January 3, 2022)
- Amended and Restated Employment Agreement by and among the Registrant, Xeris Pharmaceuticals, Inc. and Paul Edick, dated as of October 5, 2021 (Filed With SEC on October 5, 2021)
- Amended and Restated Employment Agreement by and among the Registrant, Xeris Pharmaceuticals, Inc. and John Shannon, dated as of October 5, 2021 (Filed With SEC on October 5, 2021)
- Amended and Restated Employment Agreement by and among the Registrant, Xeris Pharmaceuticals, Inc. and Steven Pieper, dated as of October 5, 2021 (Filed With SEC on October 5, 2021)